Speaker(s): 

Moderator(s): 

Michael M. O'Hara RPh, Centralized Clinical Pharmacy Services, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

1. Review the pathophysiology of Acute Coronary Syndrome (ACS).
2. Describe the medical management of ACS across multiple phases of care.
3. Identify mechanism of action, dosing, and key monitoring parameters for classes of medications used in the management of ACS. 

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Sarah F. Hale, PharmD, Daniel Longyhore, PharmD, Ed.D, BCACP, Michael M O’Hara RPh, and Mary Beth Mickel, CPhT have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None.